Yamashita Masayuki, Nitta Eriko, Suda Toshio
Department of Cell Differentiation, The Sakaguchi Laboratory of Developmental Biology, School of Medicine, Keio University, Tokyo, Japan.
The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
Ann N Y Acad Sci. 2016 Apr;1370(1):45-54. doi: 10.1111/nyas.12986. Epub 2015 Dec 22.
The majority of hematopoietic stem cells (HSCs) are maintained in a quiescent state to minimize premature exhaustion induced by various stresses. However, quiescent HSCs are vulnerable to mutagenesis because of attenuated DNA repair and DNA damage response programs. Basal abundant expression of prosurvival BCL-2 proteins further endows HSCs with high resistance to apoptosis. In contrast, HSCs elicit strong activation of p53 upon DNA damage, resulting in enhanced activation of proapoptotic BCL-2 signals through p53. ASPP1, an apoptosis-stimulating protein of p53, is highly expressed in HSCs and preserves HSC pool integrity via selective induction of apoptosis. In this paper, we discuss the role of p53 and mitochondrial apoptosis in HSC regulation and introduce the current understanding of how p53 activity is regulated to achieve a good balance between maintaining the HSC pool and preventing hematological malignancies.
大多数造血干细胞(HSC)维持在静止状态,以尽量减少各种应激诱导的过早耗竭。然而,静止的造血干细胞由于DNA修复和DNA损伤反应程序减弱而容易发生诱变。促生存BCL-2蛋白的基础丰富表达进一步赋予造血干细胞对凋亡的高抗性。相反,造血干细胞在DNA损伤时引发p53的强烈激活,导致通过p53增强促凋亡BCL-2信号的激活。ASPP1是一种p53凋亡刺激蛋白,在造血干细胞中高度表达,并通过选择性诱导凋亡来维持造血干细胞库的完整性。在本文中,我们讨论了p53和线粒体凋亡在造血干细胞调节中的作用,并介绍了目前对如何调节p53活性以在维持造血干细胞库和预防血液系统恶性肿瘤之间实现良好平衡的理解。